Seasonal variations in Vitamin D in relation to growth in short prepubertal children before and during first year growth hormone treatment

Journal of Endocrinological Investigation

Volumn 38, Issue 12, 2015, Pages 1309-1317

  Andersson, B ^a   Swolin Eide, D ^a   Kristrom B ^b   Gelander, L ^a,c   Magnusson, P ^d   Albertsson Wikland, K ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c Angered Hospital   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

25 Hydroxyvitamin D; Growth hormone; Growth response

Indexed keywords

25 HYDROXYVITAMIN D; HUMAN GROWTH HORMONE; 25-HYDROXYVITAMIN D; GROWTH HORMONE; VITAMIN D;

ARTICLE; CHILD; CHILD GROWTH; CHILDHOOD DISEASE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; SCHOOL CHILD; SEASONAL VARIATION; SHORT STATURE; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; GROWTH DISORDERS; OUTCOME ASSESSMENT; SEASON;

CHILD; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); SEASONS; VITAMIN D;

EID: 84946089028     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-015-0360-1     Document Type: Article

References (43)

1. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266-281. doi: 10.1056/NEJMra070553
2. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53-58. doi: 10.1210/jc.2010-2704
3. Holick MF (2008) Vitamin D: a D-Lightful health perspective. Nutr Rev 66(10 Suppl 2):S182-S194. doi: 10.1111/j.1753-4887.2008.00104.x
4. Stamp TC, Round JM (1974) Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 247(5442):563-565
5. Kuhn T, Kaaks R, Teucher B, Hirche F, Dierkes J, Weikert C, Katzke V, Boeing H, Stangl GI, Buijsse B (2014) Dietary, lifestyle, and genetic determinants of vitamin D status: a cross-sectional analysis from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Eur J Nutr 53(3):731-741. doi: 10.1007/s00394-013-0577-8
6. Toss G, Magnusson P (2012) Vitamin D status: sunshine is nice but other factors prevail. Eur J Nutr 51(2):255-256
7. Klaus G, Merke J, Eing H, Hugel U, Milde P, Reichel H, Ritz E, Mehls O (1991) 1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat. Calcif Tissue Int 49(5):340-348
8. Schwartz Z, Schlader DL, Ramirez V, Kennedy MB, Boyan BD (1989) Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro. J Bone Miner Res 4(2):199-207. doi: 10.1002/jbmr.5650040211
9. Schwartz Z, Brooks B, Swain L, Del Toro F, Norman A, Boyan B (1992) Production of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. Endocrinology 130(5):2495-2504
10. Gerstenfeld LC, Kelly CM, Von Deck M, Lian JB (1990) Effect of 1,25-dihydroxyvitamin D3 on induction of chondrocyte maturation in culture: extracellular matrix gene expression and morphology. Endocrinology 126(3):1599-1609
11. Yamamoto Y, Yoshizawa T, Fukuda T, Shirode-Fukuda Y, Yu T, Sekine K, Sato T, Kawano H, Aihara K, Nakamichi Y, Watanabe T, Shindo M, Inoue K, Inoue E, Tsuji N, Hoshino M, Karsenty G, Metzger D, Chambon P, Kato S, Imai Y (2013) Vitamin d receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology 154(3):1008-1020. doi: 10.1210/en.2012-1542
12. Nilsson O, Marino R, De Luca F, Phillip M, Baron J (2005) Endocrine regulation of the growth plate. Horm Res 64(4):157-165
13. Albertsson-Wikland K, Alm F, Aronsson S, Gustafsson J, Hagenas L, Hager A, Ivarsson S, Kristrom B, Marcus C, Moell C, Nilsson KO, Ritzen M, Tuvemo T, Westgren U, Westphal O, Aman J (1999) Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens. Acta Paediatr Suppl 88(428):80-84
14. Albertsson-Wikland K, Kristrom B, Lundberg E, Aronson AS, Gustafsson J, Hagenas L, Ivarsson SA, Jonsson B, Ritzen M, Tuvemo T, Westgren U, Westphal O, Aman J (2014) Growth hormone dose-dependent pubertal growth: a randomized trial in short children with low growth hormone secretion. Horm Res Paediatr 82(3):158-170. doi: 10.1159/000363106
15. Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenas L, Ivarsson SA, Jonsson B, Kristrom B, Marcus C, Nilsson KO, Ritzen EM, Tuvemo T, Westphal O, Aman J (2008) Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. J Clin Endocrinol Metab 93(11):4342-4350
16. Gelander L, Karlberg J, Albertsson-Wikland K (1994) Seasonality in lower leg length velocity in prepubertal children. Acta Paediatr 83(12):1249-1254
17. Land C, Blum WF, Stabrey A, Schoenau E (2005) Seasonality of growth response to GH therapy in prepubertal children with idiopathic growth hormone deficiency. Eur J Endocrinol 152(5):727-733. doi: 10.1530/eje.1.01899
18. Shulman DI, Frane J, Lippe B (2013) Is there "seasonal" variation in height velocity in children treated with growth hormone? Data from the national cooperative growth study. Int J Pediatr Endocrinol 1:2. doi: 10.1186/1687-9856-2013-2
19. Kristrom B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K (2009) Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature. J Clin Endocrinol Metab 94(2):483-490
20. Albertsson-Wikland K, Kristrom B, Rosberg S, Svensson B, Nierop AF (2000) Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities. Pediatr Res 48(4):475-484
21. Bodnar LM, Catov JM, Wisner KL, Klebanoff MA (2009) Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years. Br J Nutr 101(2):278-284. doi: 10.1017/S0007114508981460
22. Karlberg J (1989) On the construction of the infancy-childhood-puberty growth standard. Acta Paediatr Scand Suppl 356:26-37
23. Albertsson-Wikland K, Luo ZC, Niklasson A, Karlberg J (2002) Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference. Acta Paediatr 91(7):739-754
24. Niklasson A, Albertsson-Wikland K (2008) Continuous growth reference from 24th week of gestation to 24 months by gender. BMC Pediatr 8:8. doi: 10.1186/1471-2431-8-8
25. Karlberg J, Luo ZC, Albertsson-Wikland K (2001) Body mass index reference values (mean and SD) for Swedish children. Acta Paediatr 90(12):1427-1434
26. Luo ZC, Albertsson-Wikland K, Karlberg J (1998) Target height as predicted by parental heights in a population-based study. Pediatr Res 44(4):563-571
27. Penny R, Blizzard RM, Davis WT (1969) Sequential arginine and insulin tolerance tests on the same day. J Clin Endocrinol Metab 29(11):1499-1501. doi: 10.1210/jcem-29-11-1499
28. Albertsson-Wikland K, Rosberg S (1988) Analyses of 24 hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 67(3):493-500
29. Jansson C, Boguszewski C, Rosberg S, Carlsson L, Albertsson-Wikland K (1997) Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin Chem 43(6 Pt 1):950-956
30. Le Goff C, Peeters S, Crine Y, Lukas P, Souberbielle JC, Cavalier E (2012) Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples. Clin Chem Lab Med 50(11):2031-2032. doi: 10.1515/cclm-2012-0164
31. Löfqvist C, Andersson E, Gelander L, Rosberg S, Blum WF, Albertsson-Wikland K (2001) Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 86(12):5870-5876
32. Lofqvist C, Andersson E, Gelander L, Rosberg S, Hulthen L, Blum WF, Wikland KA (2005) Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 90(3):1420-1427
33. Wei S, Tanaka H, Kubo T, Ono T, Kanzaki S, Seino Y (1997) Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency. Eur J Endocrinol 136(1):45-51
34. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G (1993) Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 122(1):37-45
35. Ciresi A, Ciccio F, Giordano C (2014) High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment. J Endocrinol Invest 37(7):631-638. doi: 10.1007/s40618-014-0084-7
36. Hypponen E, Fararouei M, Sovio U, Hartikainen AL, Pouta A, Robertson C, Whittaker JC, Jarvelin MR (2011) High-dose vitamin D supplements are not associated with linear growth in a large Finnish cohort. J Nutr 141(5):843-848. doi: 10.3945/jn.110.133009
37. Hochberg Z (2003) Vitamin D and Rickets. S Karger AG, Basel
38. Bellone S, Esposito S, Giglione E, Genoni G, Fiorito C, Petri A, Bona G, Prodam F (2014) Vitamin D levels in a paediatric population of normal weight and obese subjects. J Endocrinol Invest 37(9):805-809. doi: 10.1007/s40618-014-0108-3
39. Holick MF, Schnoes HK, DeLuca HF, Gray RW, Boyle IT, Suda T (1972) Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. Biochemistry 11(23):4251-4255
40. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911-1930. doi: 10.1210/jc.2011-0385
41. Bailey D, Colantonio D, Kyriakopoulou L, Cohen AH, Chan MK, Armbruster D, Adeli K (2013) Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem 59(9):1393-1405. doi: 10.1373/clinchem.2013.204222
42. Franchi B, Piazza M, Sandri M, Tenero L, Comberiati P, Boner AL, Capristo C (2014) 25-hydroxyvitamin D serum level in children of different ethnicity living in Italy. Eur J Pediatr. doi: 10.1007/s00431-014-2451-y
43. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R (2013) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369(21):1991-2000. doi: 10.1056/NEJMoa1306357